From the Journals

Too few Michigan children with SCD receive pneumococcal, meningococcal vaccines

View on the News

Following special vaccine recs for children with SCD essential

This study is particularly valuable because of the “depth, breadth and completeness” of data from across an entire state, a control group that is socioeconomically matched, and a study that was done during a time when new, life-saving vaccines were licensed and recommended. The many changes in the recommendations because of new vaccines and new understanding of the best use of these vaccines make for a complex schedule, but we health care providers need to keep current and to educate parents so their children are protected against infectious diseases. For parents of children with sickle cell disease, the schedule is more complex and the need is greater because of their extreme vulnerability. Wagner et al. suggest that “a proactive electronic prompt to providers [and parents] for vaccines needed for children with special conditions [as exists for the general immunization schedule] is needed – and seems doable.”

Sarah S. Long, MD, is a professor of pediatrics at Drexel University, Philadelphia. She is an associate editor of the Journal of Pediatrics and the Red Book Report of the Committee on Infectious Diseases of the American Academy of Pediatrics. She reported no disclosures. This is a summary of her editorial accompanying the article by Wagner et al. (J. Pediatr. 2018;196:3).


 

FROM THE JOURNAL OF PEDIATRICS


The authors drew attention to the complexity of ACIP recommendations, however: ACIP released 7 recommendations a year, on average, between 2006 and 2015.

“Although providers have a responsibility to educate themselves on how best to protect children with high-risk conditions, these figures speak to the need for MCIR, the state’s immunization information system, to provide additional information on children, such as those who have sickle cell disease, who have special vaccination recommendations,” the authors wrote.

The authors reported no conflicts of interest. No external funding was noted.

SOURCE: Wagner AL et al. J Pediatr. J Pediatr. 2018 May;196:223-9.

Pages

Recommended Reading

Study: No link between vaccines, inhibitor development
MDedge Hematology and Oncology
Phase III trial: VZV protects auto-HCT patients
MDedge Hematology and Oncology
Parental reasons for HPV nonvaccination are shifting
MDedge Hematology and Oncology
Flu shots may spark immune adverse events in PD-1 blockade for NSCLC
MDedge Hematology and Oncology
Oral HPV infections sharply lower for vaccinated youth
MDedge Hematology and Oncology
Vaccination does not eliminate risk for meningococcal disease in eculizumab recipients
MDedge Hematology and Oncology
HPV vaccination rose after ACA implementation
MDedge Hematology and Oncology
Flu vaccine did not protect children with acute leukemia
MDedge Hematology and Oncology
Children with sickle cell anemia fall short on antibiotic adherence
MDedge Hematology and Oncology
High efficacy, no safety signals for herpes zoster vaccine post-HSCT
MDedge Hematology and Oncology